• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正电子发射断层扫描/计算机断层扫描与正电子发射断层扫描/磁共振成像在卵巢癌管理中的准确性系统评价:功能信息真的有必要吗?

Systematic Review on the Accuracy of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography/Magnetic Resonance Imaging in the Management of Ovarian Cancer: Is Functional Information Really Needed?

作者信息

Suppiah Subapriya, Chang Wing Liong, Hassan Hasyma Abu, Kaewput Chalermrat, Asri Andi Anggeriana Andi, Saad Fathinul Fikri Ahmad, Nordin Abdul Jalil, Vinjamuri Sobhan

机构信息

Centre for Diagnostic Nuclear Imaging, Universiti Putra Malaysia, Selangor, Malaysia.

Department of Imaging, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Selangor, Malaysia.

出版信息

World J Nucl Med. 2017 Jul-Sep;16(3):176-185. doi: 10.4103/wjnm.WJNM_31_17.

DOI:10.4103/wjnm.WJNM_31_17
PMID:28670174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5460299/
Abstract

Ovarian cancer (OC) often presents at an advanced stage with frequent relapses despite optimal treatment; thus, accurate staging and restaging are required for improving treatment outcomes and prognostication. Conventionally, staging of OC is performed using contrast-enhanced computed tomography (CT). Nevertheless, recent advances in the field of hybrid imaging have made positron emission tomography/CT (PET/CT) and PET/magnetic resonance imaging (PET/MRI) as emerging potential noninvasive imaging tools for improved management of OC. Several studies have championed the role of PET/CT for the detection of recurrence and prognostication of OC. We provide a systematic review and meta-analysis of the latest publications regarding the role of molecular imaging in the management of OC. We retrieved 57 original research articles with one article having overlap in both diagnosis and staging; 10 articles (734 patients) regarding the role of PET/CT in diagnosis of OC; 12 articles (604 patients) regarding staging of OC; 22 studies (1429 patients) for detection of recurrence; and 13 articles for prognostication and assessment of treatment response. We calculated pooled sensitivity and specificity of PET/CT performance in various aspects of imaging of OC. We also discussed the emerging role of PET/MRI in the management of OC. We aim to give the readers and objective overview on the role of molecular imaging in the management of OC.

摘要

卵巢癌(OC)通常在晚期出现,尽管进行了最佳治疗仍频繁复发;因此,准确的分期和再分期对于改善治疗效果和预后至关重要。传统上,OC的分期是使用对比增强计算机断层扫描(CT)进行的。然而,混合成像领域的最新进展使正电子发射断层扫描/计算机断层扫描(PET/CT)和正电子发射断层扫描/磁共振成像(PET/MRI)成为用于改善OC管理的新兴潜在非侵入性成像工具。几项研究支持了PET/CT在OC复发检测和预后方面的作用。我们对有关分子成像在OC管理中的作用的最新出版物进行了系统评价和荟萃分析。我们检索了57篇原创研究文章,其中一篇文章在诊断和分期方面存在重叠;10篇文章(734例患者)涉及PET/CT在OC诊断中的作用;12篇文章(604例患者)涉及OC的分期;22项研究(1429例患者)用于复发检测;13篇文章用于预后和治疗反应评估。我们计算了PET/CT在OC成像各个方面表现的合并敏感性和特异性。我们还讨论了PET/MRI在OC管理中的新兴作用。我们旨在为读者提供关于分子成像在OC管理中的作用的客观概述。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/5460299/507062b7cfe4/WJNM-16-176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/5460299/507062b7cfe4/WJNM-16-176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6531/5460299/507062b7cfe4/WJNM-16-176-g001.jpg

相似文献

1
Systematic Review on the Accuracy of Positron Emission Tomography/Computed Tomography and Positron Emission Tomography/Magnetic Resonance Imaging in the Management of Ovarian Cancer: Is Functional Information Really Needed?正电子发射断层扫描/计算机断层扫描与正电子发射断层扫描/磁共振成像在卵巢癌管理中的准确性系统评价:功能信息真的有必要吗?
World J Nucl Med. 2017 Jul-Sep;16(3):176-185. doi: 10.4103/wjnm.WJNM_31_17.
2
Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review.PET/CT与PET/MR在卵巢癌管理中的诊断性能——一项文献综述
Abdom Radiol (NY). 2021 Jun;46(6):2323-2349. doi: 10.1007/s00261-020-02847-2. Epub 2020 Nov 11.
3
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用:系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
4
New Clinical Indications for (18)F/(11)C-choline, New Tracers for Positron Emission Tomography and a Promising Hybrid Device for Prostate Cancer Staging: A Systematic Review of the Literature.(18)F/(11)C-胆碱的新临床适应证、正电子发射断层扫描的新型示踪剂和用于前列腺癌分期的有前途的混合设备:文献系统评价。
Eur Urol. 2016 Jul;70(1):161-175. doi: 10.1016/j.eururo.2016.01.029. Epub 2016 Feb 2.
5
Positron Emission Tomography/Magnetic Resonance Imaging for Local Tumor Staging in Patients With Primary Breast Cancer: A Comparison With Positron Emission Tomography/Computed Tomography and Magnetic Resonance Imaging.正电子发射断层扫描/磁共振成像用于原发性乳腺癌患者的局部肿瘤分期:与正电子发射断层扫描/计算机断层扫描及磁共振成像的比较
Invest Radiol. 2015 Aug;50(8):505-13. doi: 10.1097/RLI.0000000000000197.
6
Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.使用联合¹⁸F-氟代脱氧葡萄糖正电子发射断层扫描/磁共振成像技术降低辐射剂量对婴儿和学龄前儿童进行全面肿瘤成像:与¹⁸F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的直接比较。
Invest Radiol. 2016 Jan;51(1):7-14. doi: 10.1097/RLI.0000000000000200.
7
Staging/restaging performance of F18-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in breast cancer: A review and meta-analysis.F18-氟脱氧葡萄糖正电子发射断层扫描/磁共振成像在乳腺癌中的分期/再分期性能:综述和荟萃分析。
Eur J Radiol. 2018 Oct;107:158-165. doi: 10.1016/j.ejrad.2018.09.003. Epub 2018 Sep 5.
8
Utility of positron emission tomography/computed tomography (PET/CT) imaging in the evaluation of sarcomas: A systematic review.正电子发射断层扫描/计算机断层扫描(PET/CT)成像在肉瘤评估中的应用:系统评价。
Crit Rev Oncol Hematol. 2019 Nov;143:1-13. doi: 10.1016/j.critrevonc.2019.07.002. Epub 2019 Jul 21.
9
Diagnostic performance of CT, gadoxetate disodium-enhanced MRI, and PET/CT for the diagnosis of colorectal liver metastasis: Systematic review and meta-analysis.CT、钆塞酸二钠增强 MRI 和 PET/CT 诊断结直肠癌肝转移的诊断性能:系统评价和荟萃分析。
J Magn Reson Imaging. 2018 May;47(5):1237-1250. doi: 10.1002/jmri.25852. Epub 2017 Sep 13.
10
More advantages in detecting bone and soft tissue metastases from prostate cancer using F-PSMA PET/CT.使用F-PSMA PET/CT检测前列腺癌骨和软组织转移方面有更多优势。
Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7.

引用本文的文献

1
Evaluating the Diagnostic Performance of PET/MR Versus CECT in Determining Resectability in Ovarian Cancer.评估PET/MR与CECT在确定卵巢癌可切除性方面的诊断性能。
Cancers (Basel). 2025 Aug 9;17(16):2612. doi: 10.3390/cancers17162612.
2
Peritoneal Carcinomatosis of Malignant Gynecological Origin: A Systematic Review of Imaging Assessment.恶性妇科来源的腹膜癌病:影像学评估的系统综述
J Clin Med. 2024 Feb 22;13(5):1254. doi: 10.3390/jcm13051254.
3
18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature.

本文引用的文献

1
Use of (18)F-FDG PET/CT in the preoperative evaluation of patients diagnosed with peritoneal carcinomatosis of ovarian origin, candidates to cytoreduction and hipec. A pending issue.(18)F-FDG PET/CT在卵巢源性腹膜癌患者术前评估中的应用,这些患者是细胞减灭术和腹腔内热灌注化疗的候选者。一个悬而未决的问题。
Eur J Radiol. 2016 Oct;85(10):1824-1828. doi: 10.1016/j.ejrad.2016.08.006. Epub 2016 Aug 11.
2
Simultaneous PET/MRI vs PET/CT in oncology. A systematic review.肿瘤学中PET/MRI与PET/CT的对比:一项系统综述
Rev Esp Med Nucl Imagen Mol. 2016 Sep-Oct;35(5):306-12. doi: 10.1016/j.remn.2016.06.001. Epub 2016 Aug 8.
3
18F-FDG PET/MRI与18F-FDG PET/CT在妇科恶性肿瘤管理中的应用:文献综述
J Imaging. 2023 Oct 13;9(10):223. doi: 10.3390/jimaging9100223.
4
The Development of Nanoparticles for the Detection and Imaging of Ovarian Cancers.用于卵巢癌检测与成像的纳米颗粒的发展
Biomedicines. 2021 Oct 28;9(11):1554. doi: 10.3390/biomedicines9111554.
5
Evaluation of patients with advanced epithelial ovarian cancer before primary treatment: correlation between tumour burden assessed by [F]FDG PET/CT volumetric parameters and tumour markers HE4 and CA125.晚期上皮性卵巢癌患者初次治疗前的评估:通过[F]FDG PET/CT体积参数评估的肿瘤负荷与肿瘤标志物HE4和CA125之间的相关性
Eur Radiol. 2022 Apr;32(4):2200-2208. doi: 10.1007/s00330-021-08305-x. Epub 2021 Sep 29.
6
ADNEX Model-Based Diagnosis of Ovarian Cancer Using MRI Images.基于 ADNEX 模型的 MRI 图像卵巢癌诊断
Contrast Media Mol Imaging. 2021 Aug 18;2021:2146578. doi: 10.1155/2021/2146578. eCollection 2021.
7
EANM guideline on the role of 2-[F]FDG PET/CT in diagnosis, staging, prognostic value, therapy assessment and restaging of ovarian cancer, endorsed by the American College of Nuclear Medicine (ACNM), the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International Atomic Energy Agency (IAEA).EANM 指南:2-[F]FDG PET/CT 在卵巢癌诊断、分期、预后价值、治疗评估和再分期中的作用,得到了美国核医学学院 (ACNM)、核医学与分子成像学会 (SNMMI) 和国际原子能机构 (IAEA) 的认可。
Eur J Nucl Med Mol Imaging. 2021 Sep;48(10):3286-3302. doi: 10.1007/s00259-021-05450-9. Epub 2021 Jul 3.
8
Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review.铂敏感复发性卵巢癌二次肿瘤细胞减灭术的最新进展:一项叙述性综述
Ann Transl Med. 2021 Mar;9(6):510. doi: 10.21037/atm-20-4690.
9
Diagnostic performance of PET/CT and PET/MR in the management of ovarian carcinoma-a literature review.PET/CT与PET/MR在卵巢癌管理中的诊断性能——一项文献综述
Abdom Radiol (NY). 2021 Jun;46(6):2323-2349. doi: 10.1007/s00261-020-02847-2. Epub 2020 Nov 11.
10
Magnetic resonance imaging findings for discriminating clear cell carcinoma and endometrioid carcinoma of the ovary.卵巢透明细胞癌与子宫内膜样癌的磁共振成像特征鉴别。
J Ovarian Res. 2019 Feb 25;12(1):20. doi: 10.1186/s13048-019-0497-1.
PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
采用诊断性磁共振序列的PET/MRI与PET/CT在腹部和盆腔癌症检测中的比较
Eur J Radiol. 2016 Apr;85(4):751-9. doi: 10.1016/j.ejrad.2016.01.010. Epub 2016 Jan 21.
4
Prognostic value of (18)F-FDG PET/CT volumetric parameters in recurrent epithelial ovarian cancer.(18)F-FDG PET/CT体积参数在复发性上皮性卵巢癌中的预后价值
Rev Esp Med Nucl Imagen Mol. 2016 Mar-Apr;35(2):88-95. doi: 10.1016/j.remn.2015.08.005. Epub 2015 Nov 2.
5
18F-FDG-PET/CT can identify histopathological non-responders to platinum-based neoadjuvant chemotherapy in advanced epithelial ovarian cancer.18F-FDG-PET/CT 可识别晚期上皮性卵巢癌铂类新辅助化疗的组织病理学无应答者。
Gynecol Oncol. 2016 Jan;140(1):29-35. doi: 10.1016/j.ygyno.2015.10.018. Epub 2015 Oct 26.
6
Diagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patients.一大群卵巢癌患者中氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描的诊断和预后评估及其与血清癌抗原125(CA125)的相关性
J Turk Ger Gynecol Assoc. 2015 Aug 6;16(3):137-44. doi: 10.5152/jtgga.2015.15251. eCollection 2015.
7
Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.(18)F-FDG PET/CT对卵巢癌患者再分期的预测价值:一项多中心研究。
Eur J Nucl Med Mol Imaging. 2016 Mar;43(3):404-13. doi: 10.1007/s00259-015-3184-5. Epub 2015 Sep 18.
8
FDG-PET/CT to predict optimal primary cytoreductive surgery in patients with advanced ovarian cancer: preliminary results.18F-氟脱氧葡萄糖正电子发射断层显像/计算机断层扫描预测晚期卵巢癌患者的最佳初次肿瘤细胞减灭术:初步结果
Tumori. 2016 Jan-Feb;102(1):103-7. doi: 10.5301/tj.5000396. Epub 2015 Aug 4.
9
Implementation of FAST-PET/MRI for whole-body staging of female patients with recurrent pelvic malignancies: A comparison to PET/CT.FAST-PET/MRI在复发性盆腔恶性肿瘤女性患者全身分期中的应用:与PET/CT的比较
Eur J Radiol. 2015 Nov;84(11):2097-102. doi: 10.1016/j.ejrad.2015.08.010. Epub 2015 Aug 20.
10
Utility of PET/CT in the diagnosis of recurrent ovarian cancer depending on CA 125 serum level.根据血清CA 125水平,PET/CT在复发性卵巢癌诊断中的应用价值
Nuklearmedizin. 2015;54(4):158-62. doi: 10.3413/Nukmed-0709-14-11. Epub 2015 Jun 16.